STAT+: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more
STAT
APRIL 12, 2024
Enjoy, and see you soon… Western drug makers are talking to alternative suppliers in response to draft U.S. companies receiving federal grant money from working with four Chinese biotechs, including WuXi AppTec and its sister company WuXi Biologics, which produce active pharmaceutical ingredients for hundreds of U.S.
Let's personalize your content